C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2004
11/16/2004	US6818631 4-fluoroalkyl substituent; agriculture, horticulture; plant disease control
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096779A1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect
11/11/2004	WO2004096778A1 Substituted dihydrochinazolines having antiviral properties
11/11/2004	WO2004096777A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
11/11/2004	WO2004096755A1 Platinum complex
11/11/2004	WO2004096742A1 Hydroanthracene based compounds as anticancer agents
11/11/2004	WO2004096147A2 Oxo-pyrimidine compounds
11/11/2004	WO2004096128A2 Hiv integrase inhibitors
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	WO2004075864A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
11/11/2004	WO2004074244A3 Pyrimidine compounds
11/11/2004	WO2004011625A3 Polymorphisms for predicting disease and treatment outcome
11/11/2004	US20040225126 reacting formamide with formyl methyl alkyl ketone diacetal; distilaltion
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224992 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224965 Treatment of cardiovascular disorders, thrombosis, surgery and nhe inhibitors
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004	US20040224958 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	CA2523019A1 Hydroanthracene based compounds as anticancer agents
11/10/2004	EP1475376A1 Hair composition containing a pyrimidine-n-oxide derivative and its use to stimulate keratinic fiberes growth and/or preventing their loss
11/10/2004	EP1474149A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
11/10/2004	EP1474148A1 Treatment of neuroblastoma
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474146A1 Phenylpyrimidine amines as ige inhibitors
11/10/2004	EP1144389B1 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salt
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/09/2004	US6815543 Process for catalyzing the oxidation of organic compounds
11/09/2004	US6815398 Pre- and postemergence herbicides
11/09/2004	CA2126195C Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
11/04/2004	WO2004093880A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	WO2004093879A1 (3-{3-‘(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders
11/04/2004	WO2004069794A3 New arylpiperazinyl compounds
11/04/2004	WO2004062613A3 Hiv integrase inhibitors
11/04/2004	WO2004061084A3 Modulation of protein functionalities
11/04/2004	WO2004030629A3 Novel neurokinin antagonists and methods of use thereof
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220404 For therapy of obesity, diabetes, depression, or anxiety in a mammal
11/04/2004	US20040220271 Fungicidal active compound combinations
11/04/2004	US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220197 Hydroanthracene based compounds as anticancer agents
11/04/2004	US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220172 Uracil substituted phenyl sulfamoyl carboxamides
11/04/2004	US20040219390 Benzoxazinone and quinazolinone derivatives
11/04/2004	CA2526897A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	CA2520908A1 Aryl compounds as modulators of ppars and methods of treating metabolic disorders
11/03/2004	EP1473289A1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
11/03/2004	EP1472234A1 Quinazolinone derivatives and their use as cb agonists
11/03/2004	EP1472233A1 Pyrimidine compounds
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1399427B1 Process for the preparation of azoxystrobin and analogues thereof
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1185505B1 Method of producing methoxyimino acetic amide
11/03/2004	CN1543468A Processes for preparing calcium salt forms of statins
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543334A Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
11/03/2004	CN1543311A Selective substituted aryl ketone and safener based herbicides
11/03/2004	CN1542004A Tyrosine kinase inhibitor, preparation method and use thereof
11/03/2004	CN1542003A Preparation method and use of trimethoprim derivative
11/03/2004	CN1541532A Herbicidal synergistic composition, and method of controlling weeds
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173956C Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same
11/02/2004	US6812229 Carbamate derivative and agricultural/horticultural fungicide
11/02/2004	US6811595 Guanidinopyrimidinone compounds and phase change inks containing same
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2129040C Styryl derivatives and processes for their preparation
10/2004
10/28/2004	WO2004092196A2 Tie-2 modulators and methods of use
10/28/2004	WO2004092144A2 Quinazoline compounds useful as p38 kinase inhibitors
10/28/2004	WO2004092123A2 Inhibitors of fungal invasion
10/28/2004	WO2004092121A2 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
10/28/2004	WO2004092120A2 Pyrimidinone compounds as calcilytics
10/28/2004	WO2004092117A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004013633A3 Method for isolating atp binding proteins by means of immobolized protein inhibitors
10/28/2004	US20040214845 Barbiturates as integrin antagonists and their use for treating inflammatory diseases
10/28/2004	US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004	US20040214841 Quinazoline derivatives for treatment of tumours
10/28/2004	US20040214835 Compounds capable of activating cholinergic receptors
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug
10/28/2004	CA2522522A1 Quinazoline compounds
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521175A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004	CA2521129A1 Pyrimidinone compounds as calcilytics
10/28/2004	CA2520323A1 Tie-2 modulators and methods of use
10/27/2004	EP1471057A1 Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2
10/27/2004	EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
10/27/2004	EP1470122A1 Rho-kinase inhibitors
10/27/2004	EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors
10/27/2004	EP1470113A1 Pyrimidinone viral polymerase inhibitors
10/27/2004	EP1469854A1 Condensed heterocyclic compounds

1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 427